Variant Perception

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Where We Sit Apart From The Crowd

The market and the report agree on the direction of AUTO1's story — a profitable Merchant wholesale engine funding a narrowing Retail loss, re-rating as the model inflects. They disagree on what resolves it, when, and how clean the proof is. Stan's page already litigates the bull/bear; this page attacks the thing both sides take from the tape — consensus itself.

Our sharpest, most monetizable disagreement is near-term and measurable: consensus is capitalizing a +33% FY2026 adjusted-EBITDA acceleration that the current run-rate has not begun to deliver. The sell-side is near-unanimously long (11 of 14 buy, mean target ~$35.40, ~27% above the $27.95 spot) and the stock carries a ~38x forward multiple — yet Q1 2026 adjusted EBITDA grew only +3.0% on +21.9% unit growth, and consensus EPS has drifted down over the last 90 days (per the Catalysts and Web Research tabs). To reach the $286–315m guide midpoint, the back half has to accelerate roughly +45%. The crowd is underwriting management's flawless beat-the-guide record; the run-rate and the revisions say the risk into the 29 July H1 print is skewed to the downside, and a one-sided book on a thin float (a −18% single-day move is already on the tape) makes that skew expensive.

That is not a "the stock is cheap / the market is too pessimistic" call. It is a claim that consensus has the near-term risk skew, the quality of the headline metrics, and the watch-list segment wrong — three gaps, each with a clean resolving signal. Where we ultimately disagree with the bears too: the structural floor (Merchant out-earns the whole group) is real, so a near-term wobble is more likely an entry than a thesis-break.

Variant Scorecard

Source: analyst assessment built on the Catalysts, Numbers, Forensics, Business and Research tabs; first resolution is the H1 2026 results on 29 July 2026.

Consensus is unusually legible here (clarity 78): a tight forward multiple, a near-unanimous buy book, a quantified guide, and a management trust premium all point the same way, so there is little ambiguity about what the market believes. Variant strength is a notch lower (64) because the top disagreement is about timing and skew, not direction — the structural case is largely shared. Evidence strength (70) reflects that every claim below is already cited by an upstream tab to a primary-record page; what it cannot pin down is positioning depth, since short-interest data is absent from this run.

What The Market Believes — And The Assumption Underneath

Sources: valuation, ratings and EPS-revision signals per the Numbers and Web Research tabs; FY2026 guidance of $286–315m adjusted EBITDA from the FY2025 Annual Report [1]; the "No Corporate Debt" framing from the Q1 2026 Trading Update [2]; management track record per the People tab.

Every row above is anchored to a real consensus signal, not a vibe. The two highest-confidence beliefs — forward earnings power and management credibility — are also the two that the disagreements below put under the most pressure, because they are jointly load-bearing: the multiple only holds if the guide lands, and the guide only lands if the beat-the-guide record extends through a back half that Q1 has not yet evidenced.

The Disagreement Ledger

Sources: evidence as established in the Catalysts, Numbers, Forensics, Business and Long-Term Thesis tabs; underlying primary-record pages cited in the prose and charts below.

Disagreement 1 — The run-rate does not yet support the forward multiple (bucket: wrong time horizon)

What consensus would say: "Q1 is seasonally the weakest quarter, Retail investment is deliberately front-loaded, and this team has met or beaten eight straight adjusted-EBITDA guides — the $286–315m will land, so ~38x forward is reasonable." That is a fair, evidence-backed view.

Where our evidence disagrees: the level of acceleration the guide requires is unusually steep against what the company has actually printed. FY2025 adjusted EBITDA grew ~+81% year-on-year; Q1 2026 grew +3.0% on +21.9% units [3]; the FY2026 midpoint of $300.7m against $232.1m delivered implies ~+33% for the full year [4] [5] — and with Q1 in the bag at +3%, the residual back half has to do roughly +45%. The "growth-rate cliff" is the chart consensus is not pricing:

Source: FY2025 growth and FY2026 guide derived from reported adjusted EBITDA [6] [7]; Q1 2026 actual from the Q1 Trading Update [8].

What the market must concede if we are right: that the forward EPS curve it capitalizes ($0.72 → $1.09) is at risk of a single-digit-percent trim, which on a ~38x multiple is not a rounding error. The cleanest disconfirming signal runs the other way: an H1 print showing adjusted EBITDA growth re-accelerating into the 20s with the guide reaffirmed or raised would refute us cleanly and vindicate the crowd.

Disagreement 2 — The metrics that drive the re-rate are flattered (bucket: wrong quality of earnings)

What consensus would say: "FY2025 was record profitability — $91.5m net income, $232.1m adjusted EBITDA, GPU up in both engines. The unit economics are compounding." Where our evidence disagrees: the profit is almost entirely non-cash, and the per-unit metrics quietly lean on capitalization. Operating cash flow was −$544.1m against the $91.5m profit, with cash held flat at $709.7m only because ~$1.50bn of new ABS was drawn [9]; the Forensics tab puts the accrual ratio at +21.3%. Roughly $83.4m of refurbishment value-add was capitalized into inventory in Q4 2025 alone [10], and reported capex of $30.1m sits below D&A of $65.1m precisely because the real investment runs through inventory rather than the capex line (per Forensics). The net-income-versus-cash divergence is the picture the "record profit" headline omits:

Source: Consolidated Statement of Cash Flows and Income Statement, FY2025 Annual Report (FY2022–FY2024 from prior-year comparatives) [11].

What the market must concede if we are right: that the GPU and gross-margin slope it extrapolates is partly an accounting choice (capitalizing what could sit in COGS), so the Retail breakeven it is paying for arrives later, or shallower, than the reported per-unit line implies. The honest counter — and the cleanest refutation — is that management already publishes an ex-capitalization GPU and the auditor signed the inventory Key Audit Matter without exception; if those reconcile in FY2026, the flattering is immaterial. This is a quality-of-metrics nuance, not an allegation of fraud — note we part company with the bears here too: the cash classification itself is conservative.

Disagreement 3 — The crowd is watching the wrong segment (bucket: wrong segment)

What consensus would say: "Autohero breakeven is the catalyst; Merchant is the mature floor." Where our evidence disagrees: Merchant is not just the floor — it is also the larger, higher-probability upside lever, and it is barely switched on. Merchant earned $281.0m of segment adjusted EBITDA in FY2025, more than the entire group's $232.1m [12] [13], while Retail still lost $48.9m [14]. The single biggest undeployed GPU lever is Merchant financing attach at 17% against a 50% ambition [15] — monetizing cars already moving, needing no new market and no Autohero heroics. The segment split shows where the profit (and the option) actually lives:

Source: Merchant and Retail segment adjusted EBITDA, June 2026 Capital Markets Event [16] [17].

What the market must concede if we are right: that the re-rating trigger it is waiting on (Retail crossing zero) is the smaller and later of two value levers, and that a quarter of flat Retail does not break a thesis whose larger engine is compounding and under-monetized. This is the constructive edge — it is why a near-term wobble (Disagreement 1) reads as an entry rather than a top. What would refute it: Merchant financing attach stalling near 17%, or credit losses scaling — the $13.9m merchant-finance impairment from a flawed underwriting rollout shows that lever carries its own risk [18].

Evidence A PM Can Audit Fast

Sources: items as established in the named upstream tabs; primary-record anchors include the FY2025 cash-flow statement [19], Q4 2025 refurbishment capitalization [20], Merchant financing attach [21], and the equity-ratio decline [22].

The fragility column is the discipline: every one of these reads has a credible counter, and the strongest counters cluster on management's execution record. That is exactly why the resolution signals below — not the argument — settle it.

How This Resolves — Signals A PM Can Watch Today

Sources: signals drawn from the Catalysts, Numbers and Forensics tabs; first hard checkpoint is the 29 July 2026 H1 report against the $286–315m FY2026 guide [23].

Red Team — What Would Make Us Wrong

The case against this page is strong enough that we hold the disagreements at Medium-to-High, not High across the board:

• The Q1 softness is seasonal, not a trend. Management front-loads Retail investment and has met or beaten eight consecutive adjusted-EBITDA guides; a back-half re-acceleration is the base case from the company's own playbook, not a stretch. A clean H1 beat kills Disagreement 1 outright — and on a crowded long, that print pops the stock rather than sinking it.
• The metric-quality nuance may be immaterial. Forensics found the cash classification conservative, not manipulated; if the ex-capitalization GPU reconciles and the inventory Key Audit Matter stays clean through FY2026, Disagreement 2 is a footnote, not a re-underwrite.
• The "wrong segment" call cuts both ways. If Merchant financing attach stalls or the credit book sours — the $13.9m impairment is a live warning — then the lever we say the market under-weights is worth less than we claim, and the Retail-focused crowd was right to look past it.
• The whole near-term skew dies if the ABS window stays open and H1 re-accelerates. Then consensus is simply correct: a profitable two-engine compounder, fairly priced for its growth, and our "downside skew" was just pre-print nerves.

We would abandon the near-term variant the moment H1 shows adjusted-EBITDA growth back in the 20s with the guide intact, and abandon the metric-quality variant if FY2026 segment notes reconcile GPU to its ex-capitalization basis with stable reserves.

The One Signal To Watch First